Tailored generation of insulin producing cells from canine mesenchymal stem cells derived from bone marrow and adipose tissue
Abstract The trend of regenerative therapy for diabetes in human and veterinary practices has conceptually been proven according to the Edmonton protocol and animal models. Establishing an alternative insulin-producing cell (IPC) resource for further clinical application is a challenging task. This...
Main Authors: | Watchareewan Rodprasert, Sirirat Nantavisai, Koranis Pathanachai, Prasit Pavasant, Thanaphum Osathanon, Chenphop Sawangmake |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2021-06-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-91774-3 |
Similar Items
-
In vitro generation of transplantable insulin-producing cells from canine adipose-derived mesenchymal stem cells
by: Quynh Dang Le, et al.
Published: (2022-06-01) -
Simvastatin enhances proliferation and pluripotent gene expression by canine bone marrow-derived mesenchymal stem cells (cBM-MSCs) in vitro
by: Sirirat Nantavisai, et al.
Published: (2019-10-01) -
Corrigendum to “Simvastatin enhances proliferation and pluripotent gene expression by canine bone marrow-derived mesenchymal stem cells (cBM-MSCs) in vitro” [Heliyon 5, (10), (October 2019), e02663]
by: Sirirat Nantavisai, et al.
Published: (2019-11-01) -
Alginate/Pluronic F127-based encapsulation supports viability and functionality of human dental pulp stem cell-derived insulin-producing cells
by: Suryo Kuncorojakti, et al.
Published: (2020-08-01) -
Mesenchymal stem cell-based bone tissue engineering for veterinary practice
by: Sirirat Nantavisai, et al.
Published: (2019-11-01)